Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: Apr 22, 2024

Total Value: $1.273B (100.0% shares, 0.0% debt)

Holdings (42)

SLNO Soleno Therapeutics Inc 28.3%
Value $360M Shares 8,418,093 Est. Cost $19.93 Unrealized +127.0%
GERN Geron Corp 7.1%
Value $89.84M Shares 27,225,292 Est. Cost $1.62 Unrealized +38.1%
HRMY Harmony Biosciences Holdings Inc 6.9%
Value $87.52M Shares 2,606,247 Est. Cost $36.16 Unrealized -11.2%
SVA Sinovac Biotech Ltd. 6.0%
Value $76.35M Shares 11,800,000 Est. Cost $6.47 Unrealized 0.0%
Avadel Pharmaceuticals PLC 5.3%
Value $67.09M Shares 3,972,099 Est. Cost $8.54 Unrealized
Verona Pharma PLC 4.6%
Value $58.09M Shares 3,610,177 Est. Cost $6.97 Unrealized
ALXO ALX Oncology Holdings Inc 3.7%
Value $47.05M Shares 4,220,048 Est. Cost $39.31 Unrealized -64.3%
DYN Dyne Therapeutics Inc 3.6%
Value $46.42M Shares 1,635,136 Est. Cost $18.65 Unrealized +21.2%
TERN Terns Pharmaceuticals Inc 3.4%
Value $43.68M Shares 6,657,992 Est. Cost $11.36 Unrealized -42.5%
Astria Therapeutics Inc 2.6%
Value $32.78M Shares 2,329,027 Est. Cost $10.21 Unrealized
VRDN Viridian Therapeutics Inc 2.3%
Value $29.39M Shares 1,678,207 Est. Cost $15.47 Unrealized +25.3%
SLN Silence Therapeutics PLC 1.9%
Value $23.88M Shares 1,105,454 Est. Cost $19.65 Unrealized
OLMA Olema Pharmaceuticals Inc 1.7%
Value $21.21M Shares 1,873,704 Est. Cost $31.43 Unrealized -59.0%
Adverum Biotechnologies, Inc. 1.7%
Value $21.21M Shares 1,500,000 Est. Cost $14.14 Unrealized
Alpine Immune Sciences Inc 1.6%
Value $20.79M Shares 520,505 Est. Cost $10.28 Unrealized
TARS Tarsus Pharmaceuticals Inc 1.6%
Value $20.56M Shares 565,550 Est. Cost $28.48 Unrealized +3.2%
VSTM Verastem Inc 1.4%
Value $18.15M Shares 1,538,461 Est. Cost $6.94 Unrealized +66.5%
CRNX Crinetics Pharmaceuticals Inc 1.3%
Value $16.38M Shares 350,000 Est. Cost $20.61 Unrealized +89.9%
COGT Cogent Biosciences Inc 1.2%
Value $15.09M Shares 2,244,941 Est. Cost $8.55 Unrealized -27.7%
SERA Sera Prognostics Inc 1.2%
Value $15.02M Shares 1,650,440 Est. Cost $10.38 Unrealized -23.7%
Regulus Therapeutics Inc 1.1%
Value $14.4M Shares 5,000,000 Est. Cost $2.88 Unrealized
Tourmaline Bio Inc. 1.1%
Value $13.55M Shares 591,882 Est. Cost $26.18 Unrealized
CMPS Compass Pathway PLC 1.1%
Value $13.38M Shares 1,608,000 Est. Cost $7.40 Unrealized
ORIC Oric Pharmaceuticals Inc 0.9%
Value $11.68M Shares 849,681 Est. Cost $8.11 Unrealized +46.4%
ENGN Engene Holdings Inc. 0.9%
Value $11.5M Shares 678,705 Est. Cost $10.40 Unrealized +17.7%
Genetron Holdings Ltd 0.9%
Value $10.9M Shares 2,708,056 Est. Cost $3.68 Unrealized
IOBT IO Biotech Inc 0.8%
Value $10.68M Shares 6,173,439 Est. Cost $5.62 Unrealized -69.1%
SVRA Savara Inc 0.8%
Value $10.4M Shares 2,088,323 Est. Cost $3.59 Unrealized +34.7%
ZLAB Zai Lab Ltd 0.7%
Value $8.51M Shares 531,198 Est. Cost $42.01 Unrealized
DCTH Delcath Systems, Inc. 0.6%
Value $7.95M Shares 1,666,746 Est. Cost $5.02 Unrealized -14.1%
RZLT Rezolute Inc 0.6%
Value $7.134M Shares 2,797,704 Est. Cost $1.28 Unrealized +11.4%
CMPX Compass Therapeutics Inc 0.6%
Value $7.041M Shares 3,556,023 Est. Cost $3.60 Unrealized -51.9%
TIL Instil Bio Inc 0.5%
Value $6.743M Shares 624,338 Est. Cost $7.23 Unrealized +51.5%
QTTB Q32 Bio Inc. 0.5%
Value $6.306M Shares 370,068 Est. Cost $13.78 Unrealized 0.0%
Bolt Therapeutics Inc 0.4%
Value $4.93M Shares 3,521,291 Est. Cost $32.91 Unrealized
Unicycive Therapeutics 0.4%
Value $4.789M Shares 3,470,152 Est. Cost $0.86 Unrealized
Allakos Inc 0.3%
Value $3.765M Shares 2,988,000 Est. Cost $6.12 Unrealized
Aligos Therapeutics Inc 0.3%
Value $3.476M Shares 3,547,030 Est. Cost $27.65 Unrealized
DBV Technologies SA 0.2%
Value $2.029M Shares 2,708,875 Est. Cost $1.77 Unrealized
CDXS Codexis, Inc 0.1%
Value $1.355M Shares 388,144 Est. Cost $13.98 Unrealized -77.5%
WHWK Aadi Bioscience Inc 0.1%
Value $1.192M Shares 509,572 Est. Cost $30.48 Unrealized -93.7%
DTIL Precision Biosciences Inc 0.0%
Value $63,395 Shares 4,675 Est. Cost $12.24 Unrealized 0.0%